CSIMarket
 


West Pharmaceutical Services Inc   (WST)
Other Ticker:  
 
 

WST's Net Income Growth by Quarter and Year

West Pharmaceutical Services Inc 's Net Income results by quarter and year




WST Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 147.70 98.40 63.90
III Quarter September 120.60 175.60 82.30 56.30
II Quarter June 188.50 187.30 91.20 66.10
I Quarter March 173.80 151.20 74.30 55.40
FY   482.90 661.80 346.20 241.70



WST Net Income third quarter 2022 Y/Y Growth Comment
West Pharmaceutical Services Inc reported fall in Net Income in the third quarter 2022 by -31.32% to $ 120.60 millions, from the same quarter in 2021.
The drop in the third quarter 2022 West Pharmaceutical Services Inc 's Net Income compares unfavorably to the Company's average Net Income growth of 6.09%.

Looking into third quarter 2022 results within Medical Equipment & Supplies industry 14 other companies have achieved higher Net Income growth. While West Pharmaceutical Services Inc ' s Net Income drop of -31.32% ranks overall at the positon no. 768 in the third quarter 2022.




WST Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 50.1 % 53.99 % 22.88 %
III Quarter September -31.32 % 113.37 % 46.18 % 1.99 %
II Quarter June 0.64 % 105.37 % 37.97 % 17.83 %
I Quarter March 14.95 % 103.5 % 34.12 % 27.06 %
FY   - 91.16 % 43.24 % 16.82 %

Financial Statements
West Pharmaceutical Services Inc 's third quarter 2022 Net Income $ 120.60 millions WST's Income Statement
West Pharmaceutical Services Inc 's third quarter 2021 Net Income $ 175.60 millions Quarterly WST's Income Statement
New: More WST's historic Net Income Growth >>


WST Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -15.89 % 19.56 % 13.5 %
III Quarter September -36.02 % -6.25 % -9.76 % -14.83 %
II Quarter June 8.46 % 23.88 % 22.75 % 19.31 %
I Quarter March 17.67 % 53.66 % 16.28 % 6.54 %
FY (Year on Year)   - 91.16 % 43.24 % 16.82 %




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #61
Overall #768

Net Income Y/Y Growth Statistics
High Average Low
35.5 % 6.09 % -23.96 %
(Sep 30 2016)   (Sep. 30, 2015)
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #61
Overall #768
Net Income Y/Y Growth Statistics
High Average Low
35.5 % 6.09 % -23.96 %
(Sep 30 2016)   (Sep. 30, 2015)

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

West Pharmaceutical Services Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
2126.67 % 56.13 % -100 %
(Dec 31 2015)  


WST's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2022 West Pharmaceutical Services Inc reported fall in Net Income from the second quarter by -36.02% to $ 120.60 millions, from $ 188.50 millions achived in the previous reporting period.

If you look into recent shortcoming in the III. Quarter 2022, you must presume, that usually III. Quarter performance emerge sluggish in contrast to the preciding period, Sophie  Green, a business consultant added.

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Net Income quarter on quarter growth. While West Pharmaceutical Services Inc 's Net Income growth quarter on quarter, overall rank is 797.


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #66
Overall #797
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #66
Overall #797
Net Income Q/Q Growth Statistics
High Average Low
2126.67 % 56.13 % -100 %
(Dec 31 2015)  


WST's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2022 West Pharmaceutical Services Inc disclosed fall in Net Income from the second quarter by -36.02% to $ 120.60 millions, from $ 188.50 millions released a quarter before.

But that's not important issue, as Net Income always seem to plunge in this quarter Sophie  Green, a business consultant told.

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Net Income quarter on quarter growth. While West Pharmaceutical Services Inc 's Net Income growth quarter on quarter, overall rank is 797.


West Pharmaceutical Services Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Income 12 Months Ending $ 630.60 $ 685.60 $ 684.40 $ 661.80 $ 612.50
Y / Y Net Income Growth (TTM) 2.96 % 32.05 % 61.76 % 91.16 % 96.5 %
Year on Year Net Income Growth Overall Ranking # 528 # 137 # 133 # 344 # 526
Seqeuential Net Income Change (TTM) -8.02 % 0.18 % 3.41 % 8.05 % 17.97 %
Seq. Net Income Growth (TTM) Overall Ranking # 768 # 225 # 242 # 561 # 392




Cumulative Net Income growth Comment
With the quarterly Net Income reported in the Sep 30 2022 period, West Pharmaceutical Services Inc 's cumulative twelve months Net Income were $ 631 millions, company would post below average annual Net Income growth of 17.97% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the West Pharmaceutical Services Inc 's Net Income growth from the 188.5% growth in Jun 30 2022.

In the Healthcare sector 37 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 137 to 528.

Net Income TTM Q/Q Growth Statistics
High Average Low
35.5 %
6.09 %
-23.96 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 15
Healthcare Sector # 38
Overall # 528

Net Income TTM Y/Y Growth Statistics
High Average Low
115.09 %
36.41 %
-31.28 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 61
S&P 500 # 768
Cumulative Net Income growth Comment
With the quarterly Net Income reported in the Sep 30 2022 period, West Pharmaceutical Services Inc 's cumulative twelve months Net Income were $ 631 millions, company would post below average annual Net Income growth of -31.28% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the West Pharmaceutical Services Inc 's Net Income growth from the 188.5% growth in Jun 30 2022.

In the Healthcare sector 37 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 137 to 528.

Net Income TTM Q/Q Growth Statistics
High Average Low
35.5 %
6.09 %
-23.96 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 15
Healthcare Sector # 38
Overall # 528

Net Income TTM Y/Y Growth Statistics
High Average Low
115.09 %
36.41 %
-31.28 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 61
S&P 500 # 768




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
WST's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for WST's Competitors
Net Income Growth for West Pharmaceutical Services Inc 's Suppliers
Net Income Growth for WST's Customers

You may also want to know
WST's Annual Growth Rates WST's Profitability Ratios WST's Asset Turnover Ratio WST's Dividend Growth
WST's Roe WST's Valuation Ratios WST's Financial Strength Ratios WST's Dividend Payout Ratio
WST's Roa WST's Inventory Turnover Ratio WST's Growth Rates WST's Dividend Comparisons



Companies with similar Net Income fall for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Pediatrix Medical Group Inc -0.19%$ -0.195 millions
Addus Homecare Corporation-0.29%$ -0.294 millions
Royalty Pharma Plc-0.62%$ -0.623 millions
Zoetis Inc -4.35%$ -4.348 millions
Henry Schein Inc -4.41%$ -4.410 millions
Charles River Laboratories International inc -7.18%$ -7.177 millions
Sotera Health Company-8.58%$ -8.577 millions
U S Physical Therapy Inc-9.22%$ -9.219 millions
Ironwood Pharmaceuticals inc -9.90%$ -9.899 millions
Te Connectivity ltd -10.83%$ -10.831 millions
Semler Scientific inc -11.45%$ -11.446 millions
National Research Corporation-14.07%$ -14.073 millions
Lemaitre Vascular Inc-16.11%$ -16.113 millions
Intuitive Surgical Inc -16.14%$ -16.142 millions
Molecular Templates Inc -18.92%$ -18.919 millions
Regeneron Pharmaceuticals Inc -19.39%$ -19.391 millions
Universal Health Services Inc -19.40%$ -19.402 millions
Zynex inc -20.21%$ -20.206 millions
Progyny Inc -21.34%$ -21.344 millions
Khosla Ventures Acquisition Co -22.51%$ -22.507 millions
Tenax Therapeutics Inc -23.22%$ -23.222 millions
Maravai Lifesciences Holdings Inc -24.97%$ -24.966 millions
Reynolds Consumer Products Inc -27.27%$ -27.273 millions
Taitron Components Incorporated-28.61%$ -28.614 millions
Merck and Co Inc -28.83%$ -28.834 millions
Organon and Co -29.72%$ -29.721 millions
Gilead Sciences Inc -30.94%$ -30.936 millions
West Pharmaceutical Services Inc -31.32%$ -31.321 millions
Abbott Laboratories-31.67%$ -31.667 millions
Surgery Partners Inc -31.71%$ -31.707 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WLL's Profile

Stock Price

WLL's Financials

Business Description

Fundamentals

Charts & Quotes

WLL's News

Suppliers

WLL's Competitors

Customers & Markets

Economic Indicators

WLL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071